Advanced Practice Providers Oncology Summit.

Advancing Management Strategies in Metastatic Colon Cancer: Protocols, Targets, and Immunotherapies

Overview

This program provides an in-depth examination of metastatic colon cancer management, emphasizing current treatment protocols, molecular targets, and the role of immunotherapies. Participants will gain insights into the latest systemic therapies and learn how to incorporate genetic profiling into treatment decisions. The course also covers the significance of RAS and BRAF mutations, HER2 amplification, and explores the evolving role of immunotherapy, particularly in patients with specific genetic profiles.

Target Audience

This CME initiative was designed for oncologists, surgeons, radiation oncologists, NPs, PAs, pharmacists, nurses, and other healthcare professionals involved in the treatment of patients with cancer.

Learning Objectives

1. Review standard treatment protocols in management of first line metastatic colon cancer
2. Identify molecular targets common to colon cancer management
3. Discuss the role of immunotherapy in treatment of metastatic colon cancer  

Faculty: Valerie Lee, MD

Credit Hours: CREDIT HOURS: .75 AMA PRA Category 1 Credit™ .75 ANCC

Course Expires: 1.22.2026

Similar Courses To Consider